<article title='Chlamydia_infection'><paragraph><template><target>pp-semi</target><arg name="small">yes</arg></template><template><target>Infobox disease</target><arg name="Name"><space/>Chlamydia
</arg><arg name="Image"><space/>Pap smear showing clamydia in the vacuoles 500x H&E.jpg
</arg><arg name="Caption"><space/>[[Pap test|Pap smear]] showing ''C. trachomatis'' (H&E stain)
</arg><arg name="field"><space/>[[Infectious disease (medical specialty)|Infectious disease]], [[gynecology]], [[urology]]
</arg><arg name="ICD10"><space/>{{ICD10|A|55||a|50}}-{{ICD10|A|56|8|a|50}}, {{ICD10|A|70||a|70}}-{{ICD10|A|74|9|a|70}}
</arg><arg name="ICD9"><space/>{{ICD9|099.41}}, {{ICD9|483.1}}
</arg><arg name="ICDO">
</arg><arg name="OMIM">
</arg><arg name="DiseasesDB"><space/>2384
</arg><arg name="MedlinePlus">
</arg><arg name="eMedicineSubj"><space/>med
</arg><arg name="eMedicineTopic"><space/>340
</arg><arg name="MeshID"><space/>D002690
</arg></template><bold>Chlamydia infection</bold><space/>(from the<space/><link><target>Ancient Greek</target><part>Greek</part></link>, meaning &quot;cloak&quot;) is a common<space/><link><target>sexually transmitted disease</target><part>sexually transmitted infection</part></link><space/>in humans caused by the bacterium<space/><italics><link><target>Chlamydia trachomatis</target></link></italics>. The term<space/><italics>Chlamydia infection</italics><space/>can also refer to infection caused by any<space/><link><target>species</target></link><space/>belonging to the bacterial<space/><link><target>family (biology)</target><part>family</part></link><space/><italics><link><target>Chlamydiaceae</target></link></italics>.<space/><italics>C. trachomatis</italics><space/>is found only in humans. Chlamydia is a major infectious cause of human<space/><link><target>genital</target></link><space/>and<space/><link><target>eye disease</target></link>. Chlamydia infection is one of the most common sexually transmitted infections worldwide; it is estimated that about 1 million individuals in the<space/><link><target>United States</target></link><space/>are infected with chlamydia.<extension extension_name='ref'><template><target>cite web</target><arg name="title"><space/>STD Facts - Chlamydia<space/></arg><arg name="publisher"><space/>Center For Disease Control</arg><arg name="date">December 16, 2014<space/></arg><arg name="url"><space/>http://www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm<space/></arg><arg name="accessdate"><space/>2015-07-24<space/></arg></template></extension></paragraph><paragraph><italics>C. trachomatis</italics><space/>is naturally found living only inside human cells. Chlamydia can be transmitted during<space/><link><target>vaginal intercourse</target><part>vaginal</part></link>,<space/><link><target>anal sex</target><part>anal</part></link>, or<space/><link><target>oral sex</target></link>, and can be passed from an infected mother to her baby during<space/><link><target>childbirth</target></link>. Between half and three-quarters of all women who have a chlamydial infection of the cervix have an<space/><link><target>cervicitis</target><part>inflamed cervix</part></link><space/>without symptoms and may not realize they are infected. In men, infection by C. trachomatis can lead to<space/><link><target>urethritis</target><part>inflammation of the penile urethra</part></link><space/>causing a white discharge from the penis with or without<space/><link><target>Dysuria</target><part>a burning sensation during urination</part></link>. Occasionally, the condition spreads to the upper genital tract in women (causing<space/><link><target>pelvic inflammatory disease</target></link>) or to the<space/><link><target>epididymis</target></link><space/>in men (causing<space/><link><target>epididymitis</target><part>inflammation of the epididymis</part></link>). Chlamydia infection can be effectively cured with antibiotics. If left untreated, chlamydial infections can cause serious reproductive and other health problems with both short-term and long-term consequences.<space/><link><target>Chlamydia research</target><part>Research</part></link><space/>is ongoing in the prevention of this infection.</paragraph><paragraph>Chlamydia<space/><link><target>conjunctivitis</target></link><space/>or<space/><link><target>trachoma</target></link><space/>is a common cause of<space/><link><target>blindness</target></link><space/>worldwide. The<space/><link><target>World Health Organization</target></link><space/>(WHO) estimates that it accounted for 15% of blindness cases in 1995, but only 3.6% in 2002.<extension extension_name='ref'><template><target>cite web</target><arg name="title"><space/>CDC - Trachoma, Hygiene-related Diseases, Healthy Water<space/></arg><arg name="publisher">Center For Disease Control</arg><arg name="url"><space/>http://www.cdc.gov/healthywater/hygiene/disease/trachoma.html<space/></arg><arg name="accessdate"><space/>2015-07-24<space/></arg><arg name="date">December 28, 2009<space/></arg></template></extension><template><target>TOC limit</target><arg>3</arg></template></paragraph><heading level='2'>Signs and symptoms</heading><paragraph><template><target>refimprove section</target><arg name="date">January 2015</arg></template></paragraph><heading level='3'>Genital disease</heading><preblock><preline><link><target>File:SOA-Chlamydia-trachomatis-female.jpg</target><part>thumb</part><part><link><target>Cervicitis</target><part>Inflammation of the cervix</part></link><space/>in a female patient from chlamydia infection characterized by<space/><link><target>mucopurulent</target></link><space/><link><target>cervix</target><part>cervical</part></link><space/>discharge,<space/><link><target>erythema</target><part>redness</part></link>, and<space/><link><target>inflammation</target></link>.</part></link></preline></preblock><paragraph><link><target>File:SOA-Chlamydia-trachomatis-male.jpg</target><part>thumb</part><part>Male patients may develop a white, cloudy or watery discharge (shown) from the tip of the<space/><link><target>penis</target></link>.</part></link></paragraph><heading level='4'>Women</heading><paragraph>Chlamydial infection of the neck of the womb (<link><target>cervicitis</target></link>) is a sexually transmitted infection which is<space/><link><target>asymptomatic</target></link><space/>for 50&amp;ndash;70% of women infected with the disease. The infection can be passed through vaginal, anal, or oral sex. Of those who have an asymptomatic infection that is not detected by their doctor, approximately half will develop<space/><link><target>pelvic inflammatory disease</target></link><space/>(PID), a generic term for infection of the<space/><link><target>uterus</target></link>,<space/><link><target>fallopian tubes</target></link>, and/or<space/><link><target>ovaries</target></link>. PID can cause scarring inside the<space/><link><target>reproductive organ</target><trail>s</trail></link>, which can later cause serious complications, including chronic<space/><link><target>pelvis</target><part>pelvic</part></link><space/>pain, difficulty becoming<space/><link><target>pregnancy</target><part>pregnant</part></link>,<space/><link><target>ectopic pregnancy</target><part>ectopic (tubal) pregnancy</part></link>, and other dangerous complications of pregnancy.</paragraph><paragraph>Chlamydia is known as the &quot;Silent Epidemic&quot; because in women, it may not cause any<space/><link><target>symptom</target><trail>s</trail></link><space/>in 7080% of cases,<extension extension_name='ref' name="NHS Chlamydia page"><link type='external' href='http://www.nhs.uk/conditions/Chlamydia/Pages/Introduction.aspx'>NHS Chlamydia page</link></extension><space/>and can linger for months or years before being discovered. Signs and symptoms may include abnormal<space/><link><target>vaginal bleeding</target></link><space/>or discharge, abdominal pain,<space/><link><target>Dyspareunia</target><part>painful sexual intercourse</part></link>,<space/><link><target>fever</target></link>,<space/><link><target>Dysuria</target><part>painful urination</part></link><space/>or the urge to urinate more often than usual (<link><target>urinary urgency</target></link>).</paragraph><heading level='4'>Men</heading><paragraph>In men, those with a chlamydial infection show symptoms of infectious<space/><link><target>Urethritis</target><part>inflammation of the urethra</part></link><space/>in about 50% of cases.<extension extension_name='ref' name="NHS Chlamydia page"></extension><space/>Symptoms that may occur include: a painful or burning sensation when urinating, an unusual discharge from the<space/><link><target>penis</target></link>,<space/><link><target>Testicle</target><part>testicular</part></link><space/>pain or swelling, or fever. The purulent penile discharge is generally not as thick and is lighter in color than that for<space/><link><target>gonorrhea</target></link>.<template><target>citation needed</target><arg name="date">January 2015</arg></template><space/>If left untreated, chlamydia in men can spread to the testicles causing<space/><link><target>epididymitis</target></link>, which in rare cases can lead to<space/><link><target>infertility</target><part>sterility</part></link><space/>if not treated within 6 to 8 weeks.<template><target>citation needed</target><arg name="date">January 2015</arg></template><space/>Chlamydia is also a potential cause of<space/><link><target>prostatitis</target><part>prostatic inflammation</part></link><space/>in men, although the exact relevance in prostatitis is difficult to ascertain due to possible contamination from urethritis.<extension extension_name='ref' name="urology"><template><target>cite journal</target><arg name="author"><space/>Wagenlehner FM, Naber KG, Weidner W<space/></arg><arg name="title"><space/>Chlamydial infections and prostatitis in men<space/></arg><arg name="journal"><space/>BJU Int.<space/></arg><arg name="volume"><space/>97<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>687–90<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16536754<space/></arg><arg name="doi"><space/>10.1111/j.1464-410X.2006.06007.x<space/></arg><arg name="url"><space/>http://www.blackwell-synergy.com/openurl?genre</arg></template></extension></paragraph><heading level='3'>Eye disease</heading><paragraph><template><target>Main</target><arg>Trachoma</arg></template><link><target>File:SOA-conjunctivitis.jpg</target><part>thumb</part><part>Conjunctivitis due to chlamydia.</part></link>Chlamydia conjunctivitis or trachoma was once the most important cause of blindness worldwide, but its role diminished from 15% of blindness cases by trachoma in 1995 to 3.6% in 2002.<extension extension_name='ref' name="WHO1995"><template><target>cite journal</target><arg name="author"><space/>Thylefors B, Négrel AD, Pararajasegaram R, Dadzie KY<space/></arg><arg name="title"><space/>Global data on blindness<space/></arg><arg name="journal"><space/>Bull World Health Organ<space/></arg><arg name="volume"><space/>73<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>115–21<space/></arg><arg name="year"><space/>1995<space/></arg><arg name="pmid"><space/>7704921<space/></arg><arg name="pmc"><space/>2486591<space/></arg><arg name="doi"><space/></arg><arg name="url"><space/>http://whqlibdoc.who.int/bulletin/1995/Vol73-No1/bulletin_1995_73(1)_115-121.pdf<space/></arg></template></extension><extension extension_name='ref' name="WHO2002"><template><target>cite journal</target><arg name="author"><space/>Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP<space/></arg><arg name="title"><space/>Global data on visual impairment in the year 2002<space/></arg><arg name="journal"><space/>Bull World Health Organ<space/></arg><arg name="volume"><space/>82<space/></arg><arg name="issue"><space/>11<space/></arg><arg name="pages"><space/>844–851<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="pmid"><space/>15640920<space/></arg><arg name="pmc"><space/>2623053<space/></arg><arg name="doi"><space/>10.1590/S0042-96862004001100009<space/></arg><arg name="url"><space/>http://www.who.int/bulletin/volumes/82/11/en/844.pdf<space/></arg></template></extension><space/>The infection can be spread from eye to eye by fingers, shared towels or cloths, coughing and sneezing and eye-seeking flies.<extension extension_name='ref' name="LancetTrachoma"><template><target>cite journal</target><arg name="author"><space/>Mabey DC, Solomon AW, Foster A<space/></arg><arg name="title"><space/>Trachoma<space/></arg><arg name="journal"><space/>Lancet<space/></arg><arg name="volume"><space/>362<space/></arg><arg name="issue"><space/>9379<space/></arg><arg name="pages"><space/>223–9<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12885486<space/></arg><arg name="doi"><space/>10.1016/S0140-6736(03)13914-1<space/></arg><arg name="url"><space/>http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(03)13914-1<space/></arg></template></extension><space/>Newborns can also develop chlamydia eye infection through<space/><link><target>childbirth</target></link><space/>(see below). Using the SAFE strategy (<link><target>acronym</target></link><space/>for surgery for<space/><link><target>trichiasis</target><part>in-growing</part></link><space/>or<space/><link><target>entropion</target><part>in-turned</part></link><space/>lashes,<space/><link><target>antibiotics</target></link>, facial cleanliness, and environmental improvements), the<space/><link><target>World Health Organization</target></link><space/>aims for the global elimination of trachoma by 2020 (GET 2020 initiative).<extension extension_name='ref' name="GET2020"><link><target>World Health Organisation</target></link>.<space/><link type='external' href='http://www.who.int/blindness/causes/trachoma/en/index.html'>Trachoma</link>. Accessed March 17, 2008.</extension><extension extension_name='ref' name="LancetSAFE"><template><target>cite journal</target><arg name="author"><space/>Ngondi J, Onsarigo A, Matthews F, Reacher M, Brayne C, Baba S, Solomon AW, Zingeser J, Emerson PM<space/></arg><arg name="title"><space/>Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study<space/></arg><arg name="journal"><space/>Lancet<space/></arg><arg name="volume"><space/>368<space/></arg><arg name="issue"><space/>9535<space/></arg><arg name="pages"><space/>589–95<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16905023<space/></arg><arg name="doi"><space/>10.1016/S0140-6736(06)69202-7<space/></arg><arg name="url"><space/>http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)69202-7<space/></arg></template></extension></paragraph><heading level='3'>Joints</heading><paragraph>Chlamydia may also cause<space/><link><target>reactive arthritis</target></link>the triad of arthritis, conjunctivitis and urethral inflammationespecially in young men. About 15,000 men develop reactive arthritis due to chlamydia infection each year in the U.S., and about 5,000 are permanently affected by it. It can occur in both sexes, though is more common in men.</paragraph><heading level='3'>Infants</heading><paragraph>As many as half of all<space/><link><target>infant</target><trail>s</trail></link><space/>born to mothers with chlamydia will be born with the disease. Chlamydia can affect infants by causing spontaneous abortion;<space/><link><target>premature birth</target></link>;<space/><link><target>conjunctivitis</target></link>, which may lead to<space/><link><target>blindness</target></link>; and<space/><link><target>pneumonia</target></link>. Conjunctivitis due to chlamydia typically occurs one week after birth (compared with chemical causes (within hours) or gonorrhea (25 days)).</paragraph><heading level='3'>Other conditions</heading><paragraph>A different<space/><link><target>serovar</target></link><space/>of Chlamydia trachomatis is also the cause of<space/><link><target>lymphogranuloma venereum</target></link>, an infection of the<space/><link><target>lymph nodes</target></link><space/>and<space/><link><target>lymphatics</target></link>. It usually presents with<space/><link><target>genital ulcer</target><trail>ation</trail></link><space/>and<space/><link><target>Lymphadenopathy</target><part>swollen lymph nodes</part></link><space/>in the<space/><link><target>groin</target></link>, but it may also manifest as<space/><link><target>proctitis</target><part>rectal inflammation</part></link>,<space/><link><target>fever</target></link><space/>or swollen lymph nodes in other regions of the body.<extension extension_name='ref' name="proctitis"><template><target>cite journal</target><arg name="author"><space/>Williams D, Churchill D<space/></arg><arg name="title"><space/>Ulcerative proctitis in men who have sex with men: an emerging outbreak<space/></arg><arg name="journal"><space/>BMJ<space/></arg><arg name="volume"><space/>332<space/></arg><arg name="issue"><space/>7533<space/></arg><arg name="pages"><space/>99–100<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16410585<space/></arg><arg name="pmc"><space/>1326936<space/></arg><arg name="doi"><space/>10.1136/bmj.332.7533.99<space/></arg><arg name="url"><space/>http://bmj.com/cgi/pmidlookup?view</arg></template></extension></paragraph><heading level='2'>Transmission</heading><paragraph>Chlamydia can be transmitted during vaginal, anal, or oral sex. Chlamydia can also be passed from an infected mother to her baby during vaginal childbirth.<extension extension_name='ref'>http://www.cdc.gov/std/chlamydia/stdfact-chlamydia.htm</extension></paragraph><heading level='2'>Pathophysiology</heading><paragraph><italics>Chlamydiae</italics><space/>have the ability to establish long-term associations with host cells. When an infected host cell is starved for various nutrients such as<space/><link><target>amino acid</target><trail>s</trail></link><space/>(for example,<space/><link><target>tryptophan</target></link>),<extension extension_name='ref' name="pmid17724071"><template><target>cite journal</target><arg name="author"><space/>Leonhardt RM, Lee SJ, Kavathas PB, Cresswell P<space/></arg><arg name="title"><space/>Severe Tryptophan Starvation Blocks Onset of Conventional Persistence and Reduces Reactivation of Chlamydia trachomatis<space/></arg><arg name="journal"><space/>Infect. Immun.<space/></arg><arg name="volume"><space/>75<space/></arg><arg name="issue"><space/>11<space/></arg><arg name="pages"><space/>5105–17<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17724071<space/></arg><arg name="pmc"><space/>2168275<space/></arg><arg name="doi"><space/>10.1128/IAI.00668-07<space/></arg></template></extension><space/><link><target>iron</target></link>, or<space/><link><target>vitamin</target><trail>s</trail></link>, this has a negative consequence for<space/><italics>Chlamydiae</italics><space/>since the organism is dependent on the host cell for these nutrients. Long-term cohort studies indicate that approximately 50% of those infected clear within a year, 80% within two years, and 90% within three years.<extension extension_name='ref' name="Fairley2007"><template><target>cite journal</target><arg name="author"><space/>Fairley CK, Gurrin L, Walker J, Hocking JS<space/></arg><arg name="title"><space/>"Doctor, How Long Has My Chlamydia Been There?" Answer:"... Years"<space/></arg><arg name="journal"><space/>Sexually Transmitted Diseases<space/></arg><arg name="volume"><space/>34<space/></arg><arg name="issue"><space/>9<space/></arg><arg name="pages"><space/>727–8<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17717486<space/></arg><arg name="doi"><space/>10.1097/OLQ.0b013e31812dfb6e<space/></arg><arg name="url"><space/>http://www.stdjournal.com/pt/re/std/fulltext.00007435-200709000-00018.htm<space/></arg></template></extension></paragraph><paragraph>The starved chlamydiae enter a persistent growth state wherein they stop<space/><link><target>cell division</target></link><space/>and become morphologically aberrant by increasing in size.<extension extension_name='ref' name="pmid16338585"><template><target>cite journal</target><arg name="author"><space/>Mpiga P, Ravaoarinoro M<space/></arg><arg name="title"><space/>Chlamydia trachomatis persistence: an update<space/></arg><arg name="journal"><space/>Microbiol. Res.<space/></arg><arg name="volume"><space/>161<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>9–19<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16338585<space/></arg><arg name="doi"><space/>10.1016/j.micres.2005.04.004<space/></arg></template></extension><space/>Persistent organisms remain viable as they are capable of returning to a normal growth state once conditions in the host cell improve.</paragraph><paragraph>There is much debate as to whether persistence has<space/><italics><link><target>in vivo</target></link></italics><space/>relevance. Many believe that persistent chlamydiae are the cause of chronic chlamydial diseases. Some antibiotics such as<space/><link><target>-lactam</target><trail>s</trail></link><space/>can also induce a persistent-like growth state, which can contribute to the chronicity of chlamydial diseases.</paragraph><heading level='2'>Diagnosis</heading><paragraph><link><target>File:ChlamydiaTrachomatisEinschlusskrperchen.jpg</target><part>thumb</part><part>''Chlamydia trachomatis'' inclusion bodies (brown) in a McCoy cell culture.</part></link>The diagnosis of genital chlamydial infections evolved rapidly from the 1990s through 2006.<space/><link><target>Nucleic acid amplification test</target><trail>s</trail></link><space/>(NAAT), such as<space/><link><target>polymerase chain reaction</target></link><space/>(PCR), transcription mediated amplification (TMA), and the DNA<space/><link><target>strand displacement amplification</target></link><space/>(SDA) now are the mainstays. NAAT for chlamydia may be performed on swab specimens<space/><link><target>sampling (medicine)</target><part>sampled</part></link><space/>from the cervix (women) or urethra (men), on self-collected vaginal swabs, or on voided urine.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Gaydos CA<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="title"><space/>Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens<space/></arg><arg name="url"><space/></arg><arg name="journal"><space/>J Clin Microbio<space/></arg><arg name="volume"><space/>42<space/></arg><arg name="issue"><space/>7</arg><arg name="pages"><space/>3041–3045<space/></arg><arg name="doi"><space/>10.1128/JCM.42.7.3041-3045.2004<space/></arg><arg name="display-authors">etal</arg></template></extension><space/>NAAT has been estimated to have a<space/><link><target>sensitivity and specificity</target><part>sensitivity</part></link><space/>of approximately 90% and a<space/><link><target>sensitivity and specificity</target><part>specificity</part></link><space/>of approximately 99%, regardless of sampling from a cervical swab or by urine specimen.<extension extension_name='ref' name="Haugland2010"><template><target>cite journal</target><arg name="author"><space/>Haugland S, Thune T, Fosse B, Wentzel-Larsen T, Hjelmevoll SO, Myrmel H<space/></arg><arg name="title"><space/>Comparing urine samples and cervical swabs for Chlamydia testing in a female population by means of Strand Displacement Assay (SDA)<space/></arg><arg name="journal"><space/>BMC Womens Health<space/></arg><arg name="volume"><space/>10<space/></arg><arg name="issue"><space/>1</arg><arg name="pages"><space/>9<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20338058<space/></arg><arg name="pmc"><space/>2861009<space/></arg><arg name="doi"><space/>10.1186/1472-6874-10-9<space/></arg></template></extension><space/>In women seeking an STI clinic and a urine test is<space/><link><target>negative test</target><part>negative</part></link>, a subsequent cervical swab has been estimated to be positive in approximately 2% of the time.<extension extension_name='ref' name="Haugland2010"></extension></paragraph><paragraph>At present, the NAATs have regulatory approval only for testing urogenital specimens, although rapidly evolving research indicates that they may give reliable results on rectal specimens.</paragraph><paragraph>Because of improved test accuracy, ease of specimen management, convenience in specimen management, and ease of screening sexually active men and women, the NAATs have largely replaced culture, the historic<space/><link><target>Gold standard (test)</target><part>gold standard</part></link><space/>for chlamydia diagnosis, and the non-amplified probe tests. The latter test is relatively insensitive, successfully detecting only 6080% of infections in asymptomatic women, and often giving falsely positive results. Culture remains useful in selected circumstances and is currently the only assay approved for testing non-genital specimens.</paragraph><heading level='2'>Screening</heading><paragraph>For sexually active women who are not pregnant, screening is recommended in those under 25 and others at risk of infection.<extension extension_name='ref' name="AmFamPhys"><template><target>cite journal</target><arg name="author"><space/>Meyers D, Wolff T, Gregory K.<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="title"><space/>USPSTF Recommendations for STI Screening<space/></arg><arg name="url"><space/>http://www.aafp.org/afp/20080315/819.html<space/></arg><arg name="journal"><space/>Am Fam Physician<space/></arg><arg name="volume"><space/>77<space/></arg><arg name="issue"><space/>6</arg><arg name="pages"><space/>819–824<space/></arg><arg name="display-authors">etal</arg></template></extension><space/>Risk factors include a history of chlamydial or other sexually transmitted infection, new or multiple sexual partners, and inconsistent<space/><link><target>condom</target></link><space/>use.<extension extension_name='ref' name="USPSTF"><template><target>cite journal</target><arg name="author"><space/>U.S. Preventive Services Task Force<space/></arg><arg name="title"><space/>Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement<space/></arg><arg name="journal"><space/>Ann Intern Med<space/></arg><arg name="volume"><space/>147<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>128–34<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17576996<space/></arg><arg name="doi"><space/>10.7326/0003-4819-147-2-200707170-00172<space/></arg><arg name="url"><space/>http://www.ahrq.gov/clinic/uspstf07/chlamydia/chlamydiars.htm<space/></arg></template></extension><space/>For pregnant women, guidelines vary: screening women with age or other risk factors is recommended by the<space/><link><target>U.S. Preventive Services Task Force</target></link><space/>(USPSTF) (which recommends screening women under 25) and the<space/><link><target>American Academy of Family Physicians</target></link><space/>(which recommends screening women aged 25 or younger). The<space/><link><target>American College of Obstetricians and Gynecologists</target></link><space/>recommends screening all at risk, while the<space/><link><target>Centers for Disease Control and Prevention</target></link><space/>recommend universal screening of pregnant women.<extension extension_name='ref' name="AmFamPhys"></extension><space/>The USPSTF acknowledges that in some communities there may be other risk factors for infection, such as ethnicity.<extension extension_name='ref' name="AmFamPhys"></extension><space/>Evidence-based recommendations for screening initiation, intervals and termination are currently not possible.<extension extension_name='ref' name="AmFamPhys"></extension><space/>There is no universal agreement on screening men for chlamydia.<template><target>Why?</target><arg name="date">December 2010</arg></template></paragraph><paragraph>In the United Kingdom the<space/><link><target>National Health Service</target><part>National Health Service (NHS)</part></link><space/>aims to:</paragraph><list type='numbered'><listitem>Prevent and control chlamydia infection through early detection and treatment of asymptomatic infection;</listitem><listitem>Reduce onward transmission to sexual partners;</listitem><listitem>Prevent the consequences of untreated infection;</listitem><listitem>Test at least 25 percent of the sexually active under 25 population annually.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.chlamydiascreening.nhs.uk/ps/data/data_tables.html</arg><arg name="title">National Chlamydia Screening Programme Data tables</arg><arg name="accessdate">2009-08-28</arg></template></extension></listitem><listitem>Retest after treatment.<extension extension_name='ref' name="DesaiWoodhall2015"><template><target>cite journal</target><arg name="last1">Desai</arg><arg name="first1">Monica</arg><arg name="last2">Woodhall</arg><arg name="first2">Sarah C</arg><arg name="last3">Nardone</arg><arg name="first3">Anthony</arg><arg name="last4">Burns</arg><arg name="first4">Fiona</arg><arg name="last5">Mercey</arg><arg name="first5">Danielle</arg><arg name="last6">Gilson</arg><arg name="first6">Richard</arg><arg name="title">Active recall to increase HIV and STI testing: a systematic review</arg><arg name="journal">Sexually Transmitted Infections</arg><arg name="year">2015</arg><arg name="pages">sextrans-2014-051930</arg><arg name="issn">1368-4973</arg><arg name="doi">10.1136/sextrans-2014-051930</arg><arg name="postscript">Strategies for improved follow up care include the use of text messages and emails from those who provided treatment.</arg></template></extension></listitem></list><heading level='2'>Treatment</heading><paragraph><italics>C. trachomatis</italics><space/>infection can be effectively cured with<space/><link><target>antibiotic</target><trail>s</trail></link><space/>once it is detected. Current guidelines recommend<space/><link><target>azithromycin</target></link>,<space/><link><target>doxycycline</target></link>,<space/><link><target>erythromycin</target></link>, or<space/><link><target>ofloxacin</target></link>.<extension extension_name='ref'><template><target>cite book</target><arg name="last">al.]</arg><arg name="first">David N. Gilbert ... [et</arg><arg name="title">The Sanford guide to antimicrobial therapy 2011</arg><arg name="publisher">Antimicrobial Therapy, Inc.</arg><arg name="location">Sperryville, VA</arg><arg name="isbn">1-930808-65-8</arg><arg name="pages">20</arg></template></extension><space/>Agents recommended for pregnant women include erythromycin or<space/><link><target>amoxicillin</target></link>.<extension extension_name='ref' name="urlDiagnosis and Treatment of Chlamydia trachomatis Infection - April 15, 2006 - American Family Physician"><template><target>cite web</target><arg name="url">http://www.aafp.org/afp/2006/0415/p1411.html<space/></arg><arg name="title">Diagnosis and Treatment of Chlamydia trachomatis Infection - April 15, 2006 - American Family Physician<space/></arg><arg name="work"><space/></arg><arg name="accessdate">2010-10-30</arg></template></extension></paragraph><paragraph>An option for treating partners of patients (<link><target>index case</target><trail>s</trail></link>) diagnosed with chlamydia or<space/><link><target>gonorrhea</target></link><space/>is<space/><italics><link><target>patient-delivered partner therapy</target></link></italics><space/>(PDT or PDPT), which is the clinical practice of treating the sex partners of index cases by providing prescriptions or medications to the patient to take to his/her partner without the health care provider first examining the partner.<extension extension_name='ref' name="EPTFinalReport2006"><link type='external' href='http://www.cdc.gov/std/treatment/EPTFinalReport2006.pdf'>Expedited Partner Therapy in the Management of Sexually Transmitted Diseases (2 February 2006)</link><space/>U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE. Centers for Disease Control and Prevention National Center for HIV, STD, and TB Prevention</extension></paragraph><heading level='2'>Epidemiology</heading><paragraph>[[File:Chlamydia world map - DALY - WHO2004.svg|thumb|<link><target>Disability-adjusted life year</target></link><space/>(DALY) for chlamydia per 100,000&amp;nbsp;inhabitants in 2004.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html<space/></arg><arg name="title">WHO Disease and injury country estimates<space/></arg><arg name="year">2004<space/></arg><arg name="work">World Health Organization<space/></arg><arg name="accessdate">Nov 11, 2009</arg></template></extension><template><target>refbegin</target><arg>2</arg></template><template><target>legend</target><arg>#b3b3b3</arg><arg>no data</arg></template><template><target>legend</target><arg>#ffff65</arg><arg>≤10</arg></template><template><target>legend</target><arg>#fff200</arg><arg>10–20</arg></template><template><target>legend</target><arg>#ffdc00</arg><arg>20–30</arg></template><template><target>legend</target><arg>#ffc600</arg><arg>30–40</arg></template><template><target>legend</target><arg>#ffb000</arg><arg>40–50</arg></template><template><target>legend</target><arg>#ff9a00</arg><arg>50–60</arg></template><template><target>legend</target><arg>#ff8400</arg><arg>60–70</arg></template><template><target>legend</target><arg>#ff6e00</arg><arg>70–80</arg></template><template><target>legend</target><arg>#ff5800</arg><arg>80–90</arg></template><template><target>legend</target><arg>#ff4200</arg><arg>90–100</arg></template><template><target>legend</target><arg>#ff2c00</arg><arg>100–110</arg></template><template><target>legend</target><arg>#cb0000</arg><arg>more than 110</arg></template><template><target>refend</target></template>]]Globally, as of 2010, sexually transmitted chlamydia affects approximately 215&amp;nbsp;million people (3.1% of the population).<extension extension_name='ref' name="LancetEpi2012"></extension><space/>It is more common in women (3.8%) than men (2.5%).<extension extension_name='ref' name="LancetEpi2012"><template><target>cite journal</target><arg name="author"><space/>Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S<space/></arg><arg name="title"><space/>Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.<space/></arg><arg name="journal"><space/>Lancet<space/></arg><arg name="volume"><space/>380<space/></arg><arg name="issue"><space/>9859<space/></arg><arg name="pages"><space/>2163–96<space/></arg><arg name="date"><space/>Dec 15, 2012<space/></arg><arg name="pmid"><space/>23245607<space/></arg><arg name="doi"><space/>10.1016/S0140-6736(12)61729-2<space/></arg><arg name="display-authors">etal</arg></template></extension><space/>In that year it resulted in about 1,200 deaths down from 1,500 in 1990.<extension extension_name='ref' name="Loz2012"><template><target>cite journal</target><arg name="author"><space/>Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY<space/></arg><arg name="title"><space/>Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.<space/></arg><arg name="journal"><space/>Lancet<space/></arg><arg name="volume"><space/>380<space/></arg><arg name="issue"><space/>9859<space/></arg><arg name="pages"><space/>2095–128<space/></arg><arg name="date"><space/>Dec 15, 2012<space/></arg><arg name="pmid"><space/>23245604<space/></arg><arg name="doi"><space/>10.1016/S0140-6736(12)61728-0<space/></arg><arg name="display-authors">etal</arg></template></extension></paragraph><paragraph>CDC estimates that there are approximately 2.8 million new cases of chlamydia in the United States each year<extension extension_name='ref'><template><target>cite web</target><arg name="title">STD Trends in the United States: 2010 National Data for Gonorrhea, Chlamydia, and Syphilis</arg><arg name="url">http://www.cdc.gov/std/stats10/tables/trends-table.htm</arg><arg name="publisher">[[Centers for Disease Control and Prevention]] (CDC)</arg><arg name="date">22 November 2010</arg><arg name="accessdate">25 January 2012</arg></template></extension><space/>and that it affects around 2% of young people in that country.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Torrone</arg><arg name="first1">E</arg><arg name="last2">Papp</arg><arg name="first2">J</arg><arg name="last3">Weinstock</arg><arg name="first3">H</arg><arg name="title">Prevalence of Chlamydia trachomatis Genital Infection Among Persons Aged 14-39 Years - United States, 2007-2012.</arg><arg name="journal">MMWR. Morbidity and mortality weekly report</arg><arg name="date">Sep 26, 2014</arg><arg name="volume">63</arg><arg name="issue">38</arg><arg name="pages">834–838</arg><arg name="pmid">25254560</arg></template></extension><space/>Chlamydial infection is the most common bacterial sexually transmitted infection in the UK.<extension extension_name='ref'><template><target>cite web</target><arg name="title">Chlamydia</arg><arg name="url">http://www.hpa.org.uk/Publications/InfectiousDiseases/Factsheets/factChlamydia/</arg><arg name="publisher">UK Health Protection Agency</arg><arg name="accessdate">31 August 2012</arg></template></extension></paragraph><paragraph>Chlamydia causes more than 250,000 cases of epididymitis in the U.S. each year. Chlamydia causes 250,000 to 500,000 cases of PID every year in the United States. Women infected with chlamydia are up to five times more likely to become infected with HIV, if exposed.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.cdc.gov/std/chlamydia/STDFact-Chlamydia.htm#complications<space/></arg><arg name="title">STD Facts - Chlamydia<space/></arg><arg name="accessdate">2007-10-26<space/></arg><arg name="format"><space/></arg><arg name="work"></arg></template></extension><template><target>-</target></template></paragraph><heading level='2'>References</heading><paragraph><template><target>reflist</target><arg>2</arg></template></paragraph><heading level='2'>External links</heading><paragraph><template><target>commons category</target><arg>Chlamydia</arg></template></paragraph><list type='bullet'><listitem><template><target>dmoz</target><arg>Health/Reproductive_Health/Sexually_Transmitted_Diseases/Chlamydia/</arg></template></listitem><listitem><link type='external' href='http://www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm'>Chlamydia Fact Sheet</link><space/>from the<space/><link><target>Centers for Disease Control and Prevention</target><part>CDC</part></link></listitem><listitem><link type='external' href='http://hardinmd.lib.uiowa.edu/chlamydiapictures.html'>Links to chlamydia pictures</link><space/>at<space/><link><target>University of Iowa</target></link></listitem></list><paragraph><template><target>STD/STI</target></template></paragraph><paragraph><template><target>DEFAULTSORT:Chlamydia Infection</target></template><link><target>Category:Sexually transmitted diseases and infections</target></link><link><target>Category:Chlamydia infections</target></link><link><target>Category:Chlamydiae</target></link><link><target>Category:Infectious causes of cancer</target></link></paragraph></article>